Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
Status: Enrolling
Updated:  3/5/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
Status: Enrolling
Updated: 3/5/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
Status: Enrolling
Updated:  3/6/2014
OSF St. Francis Medical Center
mi
from
Peoria, IL
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
Status: Enrolling
Updated: 3/6/2014
OSF St. Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
Status: Enrolling
Updated:  3/10/2014
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
Status: Enrolling
Updated: 3/10/2014
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
Status: Enrolling
Updated:  3/10/2014
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
Status: Enrolling
Updated: 3/10/2014
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
Status: Enrolling
Updated:  3/10/2014
Duke Univ Med Ctr
mi
from
Durham, NC
TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
Status: Enrolling
Updated: 3/10/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
Status: Enrolling
Updated:  3/10/2014
Bayou City Research, Ltd.
mi
from
Houston, TX
TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
Status: Enrolling
Updated: 3/10/2014
Bayou City Research, Ltd.
mi
from
Houston, TX
Click here to add this to my saved trials
TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
Status: Enrolling
Updated:  3/10/2014
Westex Clinical Investigation
mi
from
Lubbock, TX
TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
Status: Enrolling
Updated: 3/10/2014
Westex Clinical Investigation
mi
from
Lubbock, TX
Click here to add this to my saved trials
Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity
Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity in People With and Without Patellofemoral Pain Syndrome
Status: Enrolling
Updated:  3/11/2014
Texas Woman's University, School of Physical Therapy - Dallas Campus
mi
from
Dallas, TX
Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity
Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity in People With and Without Patellofemoral Pain Syndrome
Status: Enrolling
Updated: 3/11/2014
Texas Woman's University, School of Physical Therapy - Dallas Campus
mi
from
Dallas, TX
Click here to add this to my saved trials
Delirium in Mechanically Ventilated Patients
An Assessment of Delirium in Mechanically Ventilated Patients Undergoing Daily Awakening From Sedation
Status: Enrolling
Updated:  3/12/2014
University of Chicago
mi
from
Chicago, IL
Delirium in Mechanically Ventilated Patients
An Assessment of Delirium in Mechanically Ventilated Patients Undergoing Daily Awakening From Sedation
Status: Enrolling
Updated: 3/12/2014
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Neural Correlates of Stress Reduction
Structural and Functional Mechanisms of Stress Reduction
Status: Enrolling
Updated:  3/14/2014
Massachusetts General Hospital
mi
from
Boston, MA
Neural Correlates of Stress Reduction
Structural and Functional Mechanisms of Stress Reduction
Status: Enrolling
Updated: 3/14/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Topiramate to Aid Smoking Cessation in Alcohol Dependent Men
Topiramate to Aid Smoking Cessation in Recovering Alcohol Dependent Men
Status: Enrolling
Updated:  3/18/2014
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Topiramate to Aid Smoking Cessation in Alcohol Dependent Men
Topiramate to Aid Smoking Cessation in Recovering Alcohol Dependent Men
Status: Enrolling
Updated: 3/18/2014
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Click here to add this to my saved trials
Combining Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors With Attentional Deficits
Combining Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors With Attentional Deficits
Status: Enrolling
Updated:  3/18/2014
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Combining Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors With Attentional Deficits
Combining Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors With Attentional Deficits
Status: Enrolling
Updated: 3/18/2014
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine
Language-based Learning Skills and ADHD: Impact of Treatment With Sustained-release Guanfacine
Status: Enrolling
Updated:  4/1/2014
Neurology Group of Bergen County
mi
from
Ridgewood, NJ
Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine
Language-based Learning Skills and ADHD: Impact of Treatment With Sustained-release Guanfacine
Status: Enrolling
Updated: 4/1/2014
Neurology Group of Bergen County
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Analyzing Female Trauma Exposed Responses to a Medication
CRF Receptor Antagonist for PTSD and Related Sleep Disturbances in Women
Status: Enrolling
Updated:  4/1/2014
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Analyzing Female Trauma Exposed Responses to a Medication
CRF Receptor Antagonist for PTSD and Related Sleep Disturbances in Women
Status: Enrolling
Updated: 4/1/2014
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Click here to add this to my saved trials
Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving
Status: Enrolling
Updated:  4/2/2014
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving
Status: Enrolling
Updated: 4/2/2014
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
Human Behavioral Pharmacology Laboratory (HBPL) Study of the Impact of the NK1 Antagonist Aprepitant (Emend®) on Stress-Induced Cocaine and Alcohol Craving
Status: Enrolling
Updated:  4/2/2014
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
Human Behavioral Pharmacology Laboratory (HBPL) Study of the Impact of the NK1 Antagonist Aprepitant (Emend®) on Stress-Induced Cocaine and Alcohol Craving
Status: Enrolling
Updated: 4/2/2014
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Effect of Oxytocin on Fear Memory Consolidation Novel Intervention to Prevent Posttraumatic Stress Disorder (PTSD)
The Effect of Oxytocin on Fear Memory Consolidation: A Novel Intervention to Prevent PTSD
Status: Enrolling
Updated:  4/7/2014
Center for Anxiety and Traumatic Disorders, MGH
mi
from
Boston, MA
The Effect of Oxytocin on Fear Memory Consolidation Novel Intervention to Prevent Posttraumatic Stress Disorder (PTSD)
The Effect of Oxytocin on Fear Memory Consolidation: A Novel Intervention to Prevent PTSD
Status: Enrolling
Updated: 4/7/2014
Center for Anxiety and Traumatic Disorders, MGH
mi
from
Boston, MA
Click here to add this to my saved trials
Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome
Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome (GTPS)
Status: Enrolling
Updated:  4/7/2014
Massachusetts General Hospital
mi
from
Boston, MA
Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome
Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome (GTPS)
Status: Enrolling
Updated: 4/7/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Using mHealth to Aid Opioid Medication Adherence Pilot Study
Using mHealth to Aid Opioid Medication Adherence Pilot Study
Status: Enrolling
Updated:  4/8/2014
Care Team Solutions
mi
from
Lexington, KY
Using mHealth to Aid Opioid Medication Adherence Pilot Study
Using mHealth to Aid Opioid Medication Adherence Pilot Study
Status: Enrolling
Updated: 4/8/2014
Care Team Solutions
mi
from
Lexington, KY
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Cerritos, CA
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Cerritos, CA
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Garden Grove, CA
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Long Beach, CA
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
National City, CA
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
National City, CA
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Oceanside, CA
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
San Diego, CA
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Washington,
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Atlanta, GA
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
St Louis, MO
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Marlton, NJ
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Marlton, NJ
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Dayton, OH
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Irving, TX
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Irving, TX
Click here to add this to my saved trials
My Life: Evaluation of Self-determination Enhancement for Adolescents in Foster Care
My Life: Evaluation of Self-Determination Enhancement for Adolescents in Foster Care
Status: Enrolling
Updated:  4/10/2014
Oregon DHS
mi
from
Portland, OR
My Life: Evaluation of Self-determination Enhancement for Adolescents in Foster Care
My Life: Evaluation of Self-Determination Enhancement for Adolescents in Foster Care
Status: Enrolling
Updated: 4/10/2014
Oregon DHS
mi
from
Portland, OR
Click here to add this to my saved trials
A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism
A Randomized Double-Blind Sham-Controlled Trial To Evaluate The Treatment Efficacy of Magnetic Resonant Therapy in Autistic Disorder
Status: Enrolling
Updated:  4/15/2014
Brain Treatment Center
mi
from
Newport Beach, CA
A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism
A Randomized Double-Blind Sham-Controlled Trial To Evaluate The Treatment Efficacy of Magnetic Resonant Therapy in Autistic Disorder
Status: Enrolling
Updated: 4/15/2014
Brain Treatment Center
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism
A Randomized Double-Blind Sham-Controlled Trial To Evaluate The Treatment Efficacy of Magnetic Resonant Therapy in Autistic Disorder
Status: Enrolling
Updated:  4/15/2014
Brain Treatment Center of Atlanta
mi
from
Buford, GA
A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism
A Randomized Double-Blind Sham-Controlled Trial To Evaluate The Treatment Efficacy of Magnetic Resonant Therapy in Autistic Disorder
Status: Enrolling
Updated: 4/15/2014
Brain Treatment Center of Atlanta
mi
from
Buford, GA
Click here to add this to my saved trials
Integrative Coping Group for Children
Treatment of Psychosomatic Pain in Youth (ToPSY): A Pilot Study
Status: Enrolling
Updated:  4/21/2014
Duke Child and Family Study Center
mi
from
Durham, NC
Integrative Coping Group for Children
Treatment of Psychosomatic Pain in Youth (ToPSY): A Pilot Study
Status: Enrolling
Updated: 4/21/2014
Duke Child and Family Study Center
mi
from
Durham, NC
Click here to add this to my saved trials
Anticoagulation in AF Ablation and Effects on Neurocognitive Function
Uninterrupted Versus Interrupted Anticoagulation in Atrial Fibrillation Ablation - Cerebral Thromboemboli and Neurocognitive Performance
Status: Enrolling
Updated:  4/21/2014
University of California - San Francisco
mi
from
San Francisco, CA
Anticoagulation in AF Ablation and Effects on Neurocognitive Function
Uninterrupted Versus Interrupted Anticoagulation in Atrial Fibrillation Ablation - Cerebral Thromboemboli and Neurocognitive Performance
Status: Enrolling
Updated: 4/21/2014
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Springdale, AK
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Springdale, AK
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Little Rock, AR
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Cerritos, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Cerritos, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Costa Mesa, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Costa Mesa, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Garden Grove, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Long Beach, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Oceanside, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Pico Rivera, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Washington,
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Bradenton, FL
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials